The Centers for Disease Control and Prevention (CDC) is offering the PPHF Epidemiology and Laboratory Capacity Program grant to measure the effectiveness of influenza vaccines against laboratory-confirmed influenza-associated hospitalizations. With the aim of evaluating the protection provided by annual vaccination programs, this grant addresses the constantly changing nature of influenza viruses and the need for annual effectiveness estimates. Eligible applicants can contribute to the ongoing effort in the United States to combat influenza and its associated morbidity, mortality, and healthcare burden.
Opportunity ID: 284108
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00202CONTPPHF16 |
| Funding Opportunity Title: | PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.733 — Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance – financed in part |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | May 24, 2016 |
| Last Updated Date: | May 26, 2016 |
| Original Closing Date for Applications: | Jun 24, 2016 |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governmentsCounty governmentsCity or township governments Special district governments Independent school districtsPublic and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.Because influenza viruses are constantly changing and vaccines are reformulated every year, annualestimates of the effectiveness of influenza vaccines in preventing influenza infection and itsassociated complications are needed in order to evaluate the protection provided by annual,nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The FOA FORMAT and title has been updated to the following: RFA-IP-15-00202CONTPPHF16; PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds |
May 26, 2016 | |
| The FOA FORMAT and title has been updated to the following: RFA-IP-15-00202CONTPPHF16; PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds |
May 26, 2016 | |
| This is NOT a solicitation for applications. Amendment II. Update the following sections with PPHF language as indicated by red text. Part 1: Overview Information Revised Funding Opportunity title to include 2016 PPHF language Revised Funding Opportunity number to include 2016 PPHF language Revised Catalog of Federal Domestic Assistance (CFDA) number(s) to add PPHF number Part 2, Section I: Funding Opportunity Description Revised funding authority to include 2016 PPHF authority Part 2, Section VI, Number 3: Additional Policy Requirements Added 2016 PPHF reporting requirements and the anti-lobbying clause |
May 26, 2016 | |
| This is NOT a solicitation for applications. Amendment II. Update the following sections with PPHF language as indicated by red text. Part 1: Overview Information Revised Funding Opportunity title to include 2016 PPHF language Revised Funding Opportunity number to include 2016 PPHF language Revised Catalog of Federal Domestic Assistance (CFDA) number(s) to add PPHF number Part 2, Section I: Funding Opportunity Description Revised funding authority to include 2016 PPHF authority Part 2, Section VI, Number 3: Additional Policy Requirements Added 2016 PPHF reporting requirements and the anti-lobbying clause |
May 24, 2016 | |
| May 24, 2016 |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00202CONTPPHF16 |
| Funding Opportunity Title: | PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.733 — Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance – financed in part |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | May 24, 2016 |
| Last Updated Date: | May 26, 2016 |
| Original Closing Date for Applications: | Jun 24, 2016 |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governmentsCounty governmentsCity or township governments Special district governments Independent school districtsPublic and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.Because influenza viruses are constantly changing and vaccines are reformulated every year, annualestimates of the effectiveness of influenza vaccines in preventing influenza infection and itsassociated complications are needed in order to evaluate the protection provided by annual,nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00202CONTPPHF16 |
| Funding Opportunity Title: | PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.733 — Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance – financed in part |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | May 26, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governmentsCounty governmentsCity or township governments Special district governments Independent school districtsPublic and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.Because influenza viruses are constantly changing and vaccines are reformulated every year, annualestimates of the effectiveness of influenza vaccines in preventing influenza infection and itsassociated complications are needed in order to evaluate the protection provided by annual,nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002PPHF16 |
| Funding Opportunity Title: | PPHF-2016-US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | May 26, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governmentsCounty governmentsCity or township governments Special district governments Independent school districtsPublic and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.Because influenza viruses are constantly changing and vaccines are reformulated every year, annualestimates of the effectiveness of influenza vaccines in preventing influenza infection and itsassociated complications are needed in order to evaluate the protection provided by annual,nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002PPHF16 |
| Funding Opportunity Title: | PPHF-2016-US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 24, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002PPHF16 |
| Funding Opportunity Title: | PPHF-2016-US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 24, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 24, 2016 |
| Archive Date: | Jul 24, 2016 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20% |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
OGS TIMS
770-488-2700 Email:OGSTIMS@cdc.gov |
Related Documents
Folder 284108 Full Announcement-RFA-IP-15-00202CONTPPHF16 -> form d instructions for applicants to compete the form.pdf
Folder 284108 Full Announcement-RFA-IP-15-00202CONTPPHF16 -> rfa-ip15-00202contpphf16 final 05 26 16.pdf
Packages
| Agency Contact Information: | OGS TIMS 770-488-2700 Email: OGSTIMS@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| NCIRD-R | PPHF 2016: PPHF Epidemiology and Laboratory Capacity Program – US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations – financed in part by 2016 Prevention and Public Health Funds | PKG00223799 | May 26, 2016 | Jun 24, 2016 | View |
Package 1
Mandatory forms
284108 RR_SF424_2_0-2.0.pdf
284108 PHS398_ResearchPlan_3_0-3.0.pdf
284108 PerformanceSite_2_0-2.0.pdf
284108 RR_OtherProjectInfo_1_3-1.3.pdf
284108 RR_KeyPersonExpanded_2_0-2.0.pdf
Optional forms
284108 RR_SubawardBudget30_1_3-1.3.pdf
284108 PHS_Inclusion_Enrollment_Report-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
